Abstract
This paper aims at analysing the restructuring of the French pharmaceutical industry through M&A and alliances. After having described some characteristics of the French pharmaceutical industry (co-existence of big pharmaceutical groups and small businesses, state politics, collaboration between public laboratory and pharmaceutical companies), we examine the concrete restructuring process in the three cases. Our purpose is to show how different agents play strategic games rather than to calculate the economic effectiveness of M&A.
